Abstract
Acute acetaminophen ingestion management includes plotting an acetaminophen concentration on the population-based Rumack-Matthew Nomogram. Nomogram implementation reflects an estimate of probability of hepatotoxicity (defined as aspartate or alanine aminotransferase >1,000 IU/L) based on ingestion time and acetaminophen concentration. Similarly, patients with unknown or repeated supratherapeutic acetaminophen exposure are treated with acetylcysteine to mitigate liver injury. Antidote efficacy is time sensitive, however, once hepatotoxicity is identified patients often have extended hospital courses and acetylcysteine administration.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
